WASHINGTON, Feb. 22 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has announced that Klonopin tablets or clonazepam, 0.125 mg and 0.25 mg, were not removed from the market due to concerns regarding safety or effectiveness. This decision clears a regulatory path for the approval of generic versions of these specific dosages. Klonopin, used to treat seizure and panic disorders, was first approved on April 9, 1997. While the brand-name manufacturer discon  more

WASHINGTON, Feb. 22 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration announced the issuance of a priority review voucher to Fondazione Telethon ETS for the development of a treatment targeting a rare pediatric condition. WASKYRA (etuvetidigene autotemcel) received approval on Dec. 9, 2025. The gene therapy is indicated for adults and pediatric patients aged 6 months and older who have Wiskott-Aldrich Syndrome (WAS). This specific patient population includ  more